Association between multimorbidity and mean platelet volume in diabetic patients with acute myocardial infarction
Autor: | Janusz Szkodzinski, Ilona Korzonek-Szlacheta, Andrzej Lekston, Mariusz Gąsior, Bartosz Hudzik, Radosław Liszka, Barbara Zubelewicz-Szkodzińska |
---|---|
Rok vydání: | 2017 |
Předmět: |
Blood Platelets
Male medicine.medical_specialty Mean platelet volume Endocrinology Diabetes and Metabolism medicine.medical_treatment Myocardial Infarction 030204 cardiovascular system & hematology Diabetic angiopathy 03 medical and health sciences Diabetes mellitus Percutaneous Coronary Intervention 0302 clinical medicine Endocrinology Internal medicine mental disorders Internal Medicine medicine Humans 030212 general & internal medicine Platelet activation Myocardial infarction Aged Retrospective Studies business.industry Multimorbidity Percutaneous coronary intervention General Medicine Middle Aged medicine.disease Comorbidity Diabetes Mellitus Type 2 Cardiology Population study Original Article Female business Diabetic Angiopathies |
Zdroj: | Acta Diabetologica |
ISSN: | 1432-5233 0940-5429 |
DOI: | 10.1007/s00592-017-1079-6 |
Popis: | Aims Diabetes mellitus (DM) is one of the most frequently detected conditions in multimorbid disease clusters. Platelet activation is one of the key mechanisms underlying atherothrombosis in acute myocardial infarction. Available data link mean platelet volume (MPV) to poor prognosis not only in cardiovascular and non-cardiovascular disease. Given the lack of research data on the association between disease clusters and MPV, we have set out to investigate the link between multimorbidity and MPV in diabetic patients with acute myocardial infarction. Methods A total of 277 patients with DM and STEMI undergoing primary percutaneous coronary intervention were enrolled. Based on the number of comorbidities the study population was divided into two groups: group 1 (N = 58) with ≤ 1 comorbidity and group 2 (N = 219) with ≥ 2 comorbidities. A subanalysis was performed within the multimorbidity group: group 2A with two or three comorbidities (N = 156) and group 2B with at least four comorbidities (N = 63). Results In the study population, 15.9% of patients had one comorbidity, and 22.0, 34.3, and 22.7% of patients had two, three, or at least four comorbid conditions, respectively. Both MPV and PDW were elevated in multimorbid patients (9.3 vs 10.8 fl and 9.5 vs 10.3 fl, respectively). The highest platelet volume indices were observed in patients with at least four comorbid conditions. There was a moderate positive correlation between MPV and the total number of comorbidities, the number of CVD comorbidities, and the number of non-CVD comorbidities. Conclusions These findings indicate that multimorbidity is associated with an increase in platelet volume indices. MPV values increased with the increasing number of comorbid conditions. Importantly, MPV values were elevated in some, but not all CVD and non-CVD conditions. |
Databáze: | OpenAIRE |
Externí odkaz: |